Patent · US Active

KRas G12C inhibitors

US10689377B2 · kind B2 · utility

5Cited by
4References
57Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 14, 2018
Grant dateJun 23, 2020
Priority date
Expiry dateNov 14, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.